Upcoming Clinical Trials and Pilot Series
The Regenerative Spine and Joint Institute takes pride not only in providing the most advance regenerative medicine interventions, but actively contributing to the scientific community with relevant clinical research. Below are some of the clinical series and future clinical research our institute will be performing.
Allogeneic Amniotic Tissue Grafts (AATG) in the treatment of early to moderate symptomatic degenerative disc disease.
Insulin Like Growth Factor (IGF) vs. Platelet Rich Plasma (PRP) vs. Allogeneic Amniotic Tissue Graft (AATG) in the treatment of ECRB tendinopathy (Tennis Elbow).
Autologous Bone Marrow Concentrate (ABMC) in the treatment of moderate degenerative disc disease. A comparison between Hyaluronic Acid (HA) and Micronized Collagen (Cellerate) as scaffolding carriers.
Adipose Derived Stromal Vascular Fraction (ADSVF)/Platelet Rich Plasma (PRP) in the treatment of moderate to advance symptomatic degenerative disc disease. Does the scaffolding affect clinical outcome.